News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Job Trends
Gilead Sciences, Inc. To Close Down Durham Office; Phase Out 150 Jobs
June 25, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Triangle Business Journal -- Gilead Sciences (Nasdaq: GILD) will close its Durham office by year’s end in a move affecting 150 workers, as the Foster City, Calif-based bio-sciences company consolidates in anti-viral research and development efforts.
Twitter
LinkedIn
Facebook
Email
Print
Job creations
Gilead Sciences, Inc.
MORE ON THIS TOPIC
Layoff Tracker
Arvinas Downsizes by 15% After Punting Pfizer-Partnered Asset
September 19, 2025
·
203 min read
·
BioSpace Editorial Staff
Layoffs
Layoffs From Just 6 Pharmas Could Wipe Out Over 39,000 Jobs
September 18, 2025
·
9 min read
·
Angela Gabriel
Job Trends
Hiring Outlook: Fewer Job Openings, High Competition Await Biopharma Job Seekers
September 11, 2025
·
4 min read
·
Angela Gabriel
Layoffs
Novo’s Headcount Rose 81% in Five Years as Revenue Climbed
September 10, 2025
·
1 min read
·
Annalee Armstrong